SHUN-FA YANGHSIANG-LIN LEECHAO-BIN YEH2026-10-162026-10-162016-07-05Pure ID: 15048525Pure UUID: 6d2c9c86-a025-4a61-9d2d-89cfd65a2ca010.7150/ijms.15853https://www.scopus.com/pages/publications/84979067077https://scholars.csmu.edu.tw/handle/123456789/30245We investigated the association between interleukin-18 (IL-18) polymorphisms and the susceptibility and clinicopathological state of hepatocellular carcinoma (HCC). In total, 901 participants, including 559 healthy controls and 342 patients with HCC, were recruited. The allelic discrimination of −607A/C (rs1946518) and −137G/C (rs187238) polymorphisms of IL-18 was assessed through real-time polymerase chain reaction by performing the TaqMan assay. The IL-18 −137G/C polymorphism but not the −607A/C polymorphism showed a significant association with the risk of HCC. Participants carrying the IL-18 −137 polymorphism with heterozygous G/C and homozygous CC genotypes showed a 1.987-fold increase (95% CI = 1.301–3.032; p = 0.001) in the risk of HCC compared with those homozygous for wild-type G/G. The 342 patients with HCC carrying the IL-18 −137G/C polymorphism were positive for hepatitis B virus (HBV) infection with an adjusted odds ratio of 1.668. Moreover, the 142 HBV positive patients with HCC and the IL-18 −137 polymorphism were positive for at least one C genotype and showed significant vascular invasion (p = 0.018). Furthermore, the level of α-fetoprotein was high in the patients carrying the IL-18 −137 polymorphism with GC+CC alleles (p = 0.011). In conclusion, the IL-18 −137G/C polymorphism with a GC+CC genotype could be a factor that increases the risk of HCC. Furthermore, the correlation between the IL-18 −137G/C polymorphism and HCC-related HBV infection is a risk factor for vascular invasion and has a synergistic effect that can further enhance HCC prognosis.6enAssociation between interleukin-18 polymorphisms and hepatocellular carcinoma occurrence and clinical progressionjournal article